• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-乙酰半胱氨酸:不仅仅是预防尿毒症患者的造影剂肾病——关注其抗氧化和抗炎特性。

N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties.

机构信息

Dialysis Unit, General Hospital of Serres, 62120, Serres, Greece.

Division of Nephrology and Hypertension, 1st Department of Internal Medicine, School of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, 54636, Thessaloniki, Greece.

出版信息

Int Urol Nephrol. 2023 Jun;55(6):1481-1492. doi: 10.1007/s11255-022-03455-3. Epub 2023 Jan 3.

DOI:10.1007/s11255-022-03455-3
PMID:36593372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10185578/
Abstract

Oxidative stress (OS) has been recognized as a pathophysiologic mechanism underlying the development and progression of chronic kidney disease (CKD). OS, which results from the disturbance of balance among pro-oxidants and antioxidants favoring the pro-oxidants, is present even in early CKD and increases progressively along with deterioration of kidney function to end-stage kidney disease (ESKD). In ESKD, OS is further exacerbated mainly due to dialysis procedures per se and predisposes to increased cardiovascular morbidity and mortality. Therefore, since OS plays a pivotal role in the pathogenesis and progression of atherosclerosis in uremic patients, several strategies aiming to ameliorate OS in these patients have been proposed. Among those, N-acetylcysteine (NAC), a thiol-containing antioxidant agent, has attracted special attention due to its pleiotropic functions and beneficial effect in various OS-related entities including paracetamol overdose and prevention of contrast-induced nephropathy. In this review, we present the currently available literature on the antioxidant and anti-inflammatory properties of NAC in CKD, including hemodialysis and peritoneal dialysis.

摘要

氧化应激(OS)已被认为是慢性肾脏病(CKD)发展和进展的病理生理机制。OS 是由于促氧化剂和抗氧化剂之间的平衡失调而导致的,即使在早期 CKD 中也存在,并且随着肾功能的恶化,其程度逐渐加重,直至终末期肾病(ESKD)。在 ESKD 中,OS 主要由于透析本身而进一步加剧,并导致心血管发病率和死亡率增加。因此,由于 OS 在尿毒症患者动脉粥样硬化的发病机制和进展中起着关键作用,因此提出了几种旨在改善这些患者 OS 的策略。其中,N-乙酰半胱氨酸(NAC)作为一种含巯基的抗氧化剂,由于其多种功能和在包括对乙酰氨基酚过量和预防造影剂肾病在内的各种与 OS 相关实体中的有益作用而受到特别关注。在这篇综述中,我们介绍了目前关于 NAC 在 CKD 中的抗氧化和抗炎特性的文献,包括血液透析和腹膜透析。

相似文献

1
N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties.N-乙酰半胱氨酸:不仅仅是预防尿毒症患者的造影剂肾病——关注其抗氧化和抗炎特性。
Int Urol Nephrol. 2023 Jun;55(6):1481-1492. doi: 10.1007/s11255-022-03455-3. Epub 2023 Jan 3.
2
Antioxidant and Anti-Inflammatory Strategies Based on the Potentiation of Glutathione Peroxidase Activity Prevent Endothelial Dysfunction in Chronic Kidney Disease.基于增强谷胱甘肽过氧化物酶活性的抗氧化和抗炎策略可预防慢性肾脏病中的内皮功能障碍。
Cell Physiol Biochem. 2018;51(3):1287-1300. doi: 10.1159/000495540. Epub 2018 Nov 27.
3
Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?抗氧化剂补充能否延缓终末期肾病患者心血管疾病的进展?
Curr Vasc Pharmacol. 2021;19(1):41-54. doi: 10.2174/1570161118666200317151553.
4
N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system.N-乙酰半胱氨酸作为一种潜在的策略,可减轻尿毒症血清在血管系统中引起的氧化应激。
Life Sci. 2015 Jan 15;121:110-6. doi: 10.1016/j.lfs.2014.11.024. Epub 2014 Dec 10.
5
The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.抗氧化剂乙酰半胱氨酸可降低终末期肾衰竭患者的心血管事件:一项随机对照试验。
Circulation. 2003 Feb 25;107(7):992-5. doi: 10.1161/01.cir.0000050628.11305.30.
6
Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.N-乙酰半胱氨酸在慢性阻塞性肺疾病中的病理过程、分子生物学及临床应用的最新进展
Int J Chron Obstruct Pulmon Dis. 2014 Aug 6;9:825-36. doi: 10.2147/COPD.S51057. eCollection 2014.
7
Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?抗氧化剂补充治疗在肾脏替代治疗患者中的应用:有证据支持吗?
Oxid Med Cell Longev. 2019 Jan 15;2019:9109473. doi: 10.1155/2019/9109473. eCollection 2019.
8
Is oxidative stress an issue in peritoneal dialysis?氧化应激是腹膜透析中的一个问题吗?
Semin Dial. 2019 Sep;32(5):463-466. doi: 10.1111/sdi.12818. Epub 2019 May 1.
9
Protective effect of N-acetylcysteine on progression to end-stage renal disease: Necessity for prospective clinical trial.N-乙酰半胱氨酸对终末期肾病进展的保护作用:前瞻性临床试验的必要性。
Eur J Intern Med. 2017 Oct;44:67-73. doi: 10.1016/j.ejim.2017.06.011. Epub 2017 Jun 17.
10
Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study.口服 N-乙酰半胱氨酸治疗对腹膜透析患者血浆炎症和氧化应激标志物的影响:一项安慰剂对照研究。
Perit Dial Int. 2010 May-Jun;30(3):336-42. doi: 10.3747/pdi.2009.00073. Epub 2010 Feb 26.

引用本文的文献

1
N-Acetylcysteine to Reduce Kidney and Liver Injury Associated with Drug-Resistant Tuberculosis Treatment.N-乙酰半胱氨酸可减轻耐多药结核病治疗相关的肾肝损伤。
Pharmaceutics. 2025 Apr 15;17(4):516. doi: 10.3390/pharmaceutics17040516.
2
Antibodies Against Anti-Oxidant Enzymes in Autoimmune Glomerulonephritis and in Antibody-Mediated Graft Rejection.自身免疫性肾小球肾炎及抗体介导的移植排斥反应中针对抗氧化酶的抗体
Antioxidants (Basel). 2024 Dec 12;13(12):1519. doi: 10.3390/antiox13121519.
3
Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path.

本文引用的文献

1
Association between Biomarkers of Oxidative Stress and Inflammation with Cardiac Necrosis and Heart Failure in Non-ST Segment Elevation Myocardial Infarction Patients and Various Degrees of Kidney Function.氧化应激和炎症生物标志物与非 ST 段抬高型心肌梗死患者及不同程度肾功能的心肌坏死和心力衰竭的关系。
Oxid Med Cell Longev. 2021 Nov 1;2021:3090120. doi: 10.1155/2021/3090120. eCollection 2021.
2
N-acetylcysteine for chronic kidney disease: a systematic review and meta-analysis.N-乙酰半胱氨酸用于慢性肾脏病:一项系统评价与荟萃分析
Am J Transl Res. 2021 Apr 15;13(4):2472-2485. eCollection 2021.
3
Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.
透析患者慢性心力衰竭的管理:一条充满挑战但回报丰厚的道路。
Rev Cardiovasc Med. 2024 Jun 25;25(6):232. doi: 10.31083/j.rcm2506232. eCollection 2024 Jun.
4
Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction.单侧输尿管梗阻所致肾纤维化的发病机制与管理
Kidney Res Clin Pract. 2024 Sep;43(5):586-599. doi: 10.23876/j.krcp.23.156. Epub 2024 Feb 6.
5
Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy).内源性和外源性抗氧化剂作为预防造影剂负面影响(造影剂诱发的肾病)的药物。
Pharmaceuticals (Basel). 2023 Jul 28;16(8):1077. doi: 10.3390/ph16081077.
N-乙酰半胱氨酸对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者预防对比剂相关急性肾损伤的效果:一项随机对照试验的系统评价和荟萃分析。
BMJ Open. 2020 Oct 16;10(10):e039009. doi: 10.1136/bmjopen-2020-039009.
4
Latest Clinical Evidence About Effect of Acetylcysteine on Preventing Contrast-Induced Nephropathy in Patients Undergoing Angiography: A Meta-Analysis.最新临床证据表明乙酰半胱氨酸对接受血管造影检查患者预防造影剂肾病的影响:一项荟萃分析。
Angiology. 2021 Feb;72(2):105-121. doi: 10.1177/0003319720950162. Epub 2020 Aug 24.
5
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update.慢性肾脏病中的内皮功能障碍:从生物学机制到临床结局——2020年更新
J Clin Med. 2020 Jul 23;9(8):2359. doi: 10.3390/jcm9082359.
6
Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress.腹膜透析液对腹膜的不良影响:氧化应激的作用。
Biomolecules. 2020 May 14;10(5):768. doi: 10.3390/biom10050768.
7
N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.N-乙酰半胱氨酸(NAC),一种抗氧化剂,不能改善进行性慢性肾脏病-矿物质和骨异常大鼠模型的骨力学性能。
PLoS One. 2020 Mar 23;15(3):e0230379. doi: 10.1371/journal.pone.0230379. eCollection 2020.
8
Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?抗氧化剂补充能否延缓终末期肾病患者心血管疾病的进展?
Curr Vasc Pharmacol. 2021;19(1):41-54. doi: 10.2174/1570161118666200317151553.
9
Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread.慢性肾脏病发病机制和演变中的氧化应激:解开阿里阿德涅的线团。
Int J Mol Sci. 2019 Jul 29;20(15):3711. doi: 10.3390/ijms20153711.
10
Is oxidative stress an issue in peritoneal dialysis?氧化应激是腹膜透析中的一个问题吗?
Semin Dial. 2019 Sep;32(5):463-466. doi: 10.1111/sdi.12818. Epub 2019 May 1.